Evidence map›Paper›PMID 40568879›Full record

ArticleAccounts of chemical research2025

Kinetics, Thermodynamics, and Emergence in Stereoediting Reactions.

Gino Occhialini, Alison E Wendlandt

Abstract read
In one paragraph

Article in Accounts of chemical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Gino OcchialiniDepartment of Chemistry, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, United States.ORCID 0000-0001-9682-1740
Alison E WendlandtDepartment of Chemistry, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, United States.ORCID 0000-0003-2970-9817

Funding

Late Stage Stereochemical Editing to Transform the Synthesis of Bioactive MoleculesDP2GM146248 · NIGMS · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI WENDLANDT, ALISON · 2021 to 2024
$2.1M
Selective Catalytic Strategies for Carbohydrate SynthesisR01GM141275 · NIGMS · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI WENDLANDT, ALISON · 2022 to 2025
$1.3M
NIGMS NIH HHS DP2 GM146248NIGMS NIH HHS R01 GM141275
6 · The paper itself

Abstract

ConspectusThe selective formation of one stereoisomer over another is a long-standing challenge in organic chemistry. Conventionally, the configuration of a stereogenic center is defined during bond forming molecular assembly steps and thereafter treated as a static component of the molecular structure. One isomer is often more accessible than others, because it can be obtained directly from natural sources, because synthetic strategies to access certain stereochemical patterns are more efficient than others, or because substrate-based steric and electronic biases preclude certain reaction outcomes. In such cases, the ability to revise the stereochemistry without altering the underlying molecular skeleton could parlay more accessible products directly into more challenging targets.In this Account, we describe our efforts to develop stereocenter editing tools to enable the interconversion of stereoisomers with a predictable and tunable selectivity. Stereoediting methods developed by our lab leverage radical intermediates accessed by sequential H atom abstraction and donation steps promoted by a range of different H atom transfer reagents. Modern photoredox methods enable access to reactive radical intermediates under mild reaction conditions, serve as an orthogonal stimulus to induce dynamic character from otherwise static structures, and provide ample fuel to drive

Identifiers

PMID40568879
PMCPMC13242281

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.